Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats.
Tissue and Cell（2020）
Abstract
•Liraglutide and hUC-MSCs can improve the regulation of T2DM with NAFLD.•The mechanism was related to the TLR4/NF-κB inflammatory pathway and oxidative stress.•There is no such basic research.
MoreTranslated text
Key words
Non-alcoholic fatty liver disease,Type 2 diabetes mellitus,Liraglutide,Human umbilical cord mesenchymal stem cell,TLR4/NF-κB,Oxidative stress
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined